THE MAIN ASPECTS OF THE DISEASE OF CHRONIC HEART FAILURE AND COVID-19 INDUCED CARDIOMYOPATHY
The coronavirus pandemic has damaged the healthcare system since its outbreak in 2020 and has led to more than 6 million deaths worldwide, and in Kazakhstan more than 13 thousand. The clinical manifestations of COVID19 range from asymptomatic carrier to severe pneumonia and lifethreatening acute respiratory distress syndrome (ARDS). The rst efforts of the pandemic were aimed at treating the pulmonary component of COVID19, but there is reliable data on cardiac complications associated with the virus. It is assumed that this is caused by a pronounced in ammatory reaction, as well as direct viral damage. Arrhythmias, acute myocardial injury, myocarditis, cardiomyopathy, thrombosis and myocardial brosis are some of the observed cardiac complications. There are high rates of morbidity and mortality among people sufering from heart diseases associated with COVID-19